The incoming administration will likely bring policy changes, new leadership appointments, and administrative actions that could significantly impact pharmaceuticals, insurance, and healthcare facilities in the U.S.
We surveyed HCPs to understand what they are most concerned about — including Medicare/Medicaid, access to care, and regulation of private insurance — and how these potential changes could impact their practice.
Download our full report to gain insight into how HCPs are preparing for the potential impact of the new administration.